184 related articles for article (PubMed ID: 9804061)
1. Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats.
Hanatani A; Yoshiyama M; Takeuchi K; Kim S; Nakayama K; Omura T; Iwao H; Yoshikawa J
Jpn J Pharmacol; 1998 Sep; 78(1):45-54. PubMed ID: 9804061
[TBL] [Abstract][Full Text] [Related]
2. Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography.
Yoshiyama M; Takeuchi K; Omura T; Kim S; Yamagishi H; Toda I; Teragaki M; Akioka K; Iwao H; Yoshikawa J
Hypertension; 1999 Apr; 33(4):961-8. PubMed ID: 10205231
[TBL] [Abstract][Full Text] [Related]
3. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats.
Shimada T; Yoshiyama M; Takeuchi K; Omura T; Takemoto Y; Kim S; Iwao H; Yoshikawa J
Cardiovasc Res; 1998 Mar; 37(3):618-26. PubMed ID: 9659445
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
Ambrose J; Pribnow DG; Giraud GD; Perkins KD; Muldoon L; Greenberg BH
J Cardiovasc Pharmacol; 1999 Mar; 33(3):433-9. PubMed ID: 10069680
[TBL] [Abstract][Full Text] [Related]
5. Differences in time course of myocardial mRNA expression in non-infarcted myocardium after myocardial infarction.
Omura T; Yoshiyama M; Takeuchi K; Hanatani A; Kim S; Yoshida K; Izumi Y; Iwao H; Yoshikawa J
Basic Res Cardiol; 2000 Aug; 95(4):316-23. PubMed ID: 11005587
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction.
Kusuyama T; Yoshiyama M; Omura T; Nishiya D; Enomoto S; Matsumoto R; Izumi Y; Akioka K; Takeuchi K; Iwao H; Yoshikawa J
J Pharmacol Sci; 2005 Jul; 98(3):283-9. PubMed ID: 15997171
[TBL] [Abstract][Full Text] [Related]
7. Doppler echocardiographic assessment and cardiac gene expression analysis of the left ventricle in myocardial infarcted rats.
Shimizu N; Yoshiyama M; Takeuchi K; Hanatani A; Kim S; Omura T; Iwao H; Yoshikawa J
Jpn Circ J; 1998 Jun; 62(6):436-42. PubMed ID: 9652320
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction.
Hanatani A; Yoshiyama M; Kim S; Omura T; Toda I; Akioka K; Teragaki M; Takeuchi K; Iwao H; Takeda T
J Mol Cell Cardiol; 1995 Sep; 27(9):1905-14. PubMed ID: 8523451
[TBL] [Abstract][Full Text] [Related]
9. Effect of cilazapril on ventricular remodeling assessed by Doppler-echocardiographic assessment and cardiac gene expression.
Yoshiyama M; Takeuchi K; Hanatani A; Shimada T; Takemoto Y; Shimizu N; Omura T; Kim S; Iwao H; Yoshikawa J
Cardiovasc Drugs Ther; 1998 Mar; 12(1):57-70. PubMed ID: 9607133
[TBL] [Abstract][Full Text] [Related]
10. Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.
Matsumoto R; Yoshiyama M; Omura T; Kim S; Nakamura Y; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
Circ J; 2004 Apr; 68(4):376-82. PubMed ID: 15056838
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix.
Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Nakayama H; Otsu K; Suzuki K; Tada M; Hori M; Miwa T; Masuyama T
J Hypertens; 2003 Sep; 21(9):1737-45. PubMed ID: 12923407
[TBL] [Abstract][Full Text] [Related]
13. Effect of diltiazem on cardiac remodeling in rats assessed by Doppler echocardiography and mRNA expression.
Yoshiyama M; Takeuchi K; Omura T; Izutani S; Nakamura Y; Akioka K; Kim S; Iwao H; Yoshikawa J
Cardiovasc Drugs Ther; 1999 May; 13(3):249-58. PubMed ID: 10439888
[TBL] [Abstract][Full Text] [Related]
14. Differences in expression of sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger genes between adjacent and remote noninfarcted myocardium after myocardial infarction.
Yoshiyama M; Takeuchi K; Hanatani A; Kim S; Omura T; Toda I; Teragaki M; Akioka K; Iwao H; Yoshikawa J
J Mol Cell Cardiol; 1997 Jan; 29(1):255-64. PubMed ID: 9040040
[TBL] [Abstract][Full Text] [Related]
15. Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.
Takeuchi K; Omura T; Yoshiyama M; Yoshida K; Otsuka R; Shimada Y; Ujino K; Yoshikawa J
Heart Vessels; 1999; 14(3):111-9. PubMed ID: 10776803
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats.
Soga M; Kamal FA; Watanabe K; Ma M; Palaniyandi S; Prakash P; Veeraveedu P; Mito S; Kunisaki M; Tachikawa H; Kodama M; Aizawa Y
Int J Cardiol; 2006 Jun; 110(3):378-85. PubMed ID: 16324756
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
18. Nipradilol can prevent left ventricular systolic and diastolic dysfunction after myocardial infarction in rats.
Izutani S; Yoshiyama M; Omura T; Yoshida K; Nakamura Y; Kim S; Takeuchi K; Yoshikawa J
Circ J; 2002 Mar; 66(3):289-93. PubMed ID: 11922280
[TBL] [Abstract][Full Text] [Related]
19. Alterations in sarcoplasmic reticulum and angiotensin II type 1 receptor gene expression after myocardial infarction in rats.
Iijima K; Geshi E; Nomizo A; Arata Y; Katagiri T
Jpn Circ J; 1998 Jun; 62(6):449-54. PubMed ID: 9652322
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cardiac function and gene expression at an early phase after myocardial infarction.
Hanatani A; Yoshiyama M; Kim S; Omura T; Ikuno Y; Takeuchi K; Iwao H; Yoshikawa J
Jpn Heart J; 1998 May; 39(3):375-88. PubMed ID: 9711189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
